Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy

International Review of Psychiatry

Volumn 25, Issue 2, 2013, Pages 197-209

  Bruns, Marla B ^a   Josephs, Keith A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; PLACEBO;

ALZHEIMER DISEASE; APATHY; ARTICLE; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL (TOPIC); CORTICOBASAL DEGENERATION; DEPRESSION; DISEASE COURSE; DRUG WITHDRAWAL; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; HUMAN; MOTOR DYSFUNCTION; NEUROANATOMY; NEUROPATHOLOGY; NEUROPSYCHIATRY; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PSYCHOPHARMACOLOGY; SYMPTOM; UNSPECIFIED SIDE EFFECT;

BASAL GANGLIA; CEREBRAL CORTEX; HUMANS; NEUROPSYCHOLOGICAL TESTS; PARKINSONIAN DISORDERS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84876746108     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.3109/09540261.2013.766154     Document Type: Article

References (92)

1. Aarsland, D., Litvan, I. & Larsen, J.P. (2001). Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 13, 42 - 49
2. Armstrong, M.J., Litvan, I., Lang, A.E., Bak, T.H., Bhatia, K.P., Borroni, B.,.Weiner, W.J. (2013). Criteria for the diagnosis of corticobasal degeneration. [Multicenter Study Research Support, Non-U.S. Gov't]. Neurology, 80, 496 - 503
3. Bak, T.H., Caine, D., Hearn, V.C. & Hodges, J.R. (2006). Visuospatial functions in atypical Parkinsonian syndromes. Journal of Neurology, Neurosurgery, and Psychiatry, 77, 454 - 456
4. Bak, T.H., Crawford, L.M., Berrios, G. & Hodges, J.R. (2010). Behavioural symptoms in progressive supranuclear palsy and frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 81, 1057 - 1059
5. Bak, T.H., & Hodges, J.R. (2008). Corticobasal degeneration: Clinical aspects. Handbook of clinical neurology/edited by P.J. Vinken and G.W. Bruyn, 89, 509 - 521
6. Bergeron, C., Pollanen, M.S., Weyer, L. & Lang, A.E. (1997). Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. Journal of Neuropathology and Experimental Neurology, 56, 726 - 734
7. Blin, J., Baron, J.C., Dubois, B., Pillon, B., Cambon, H., Cambier, J. & Agid, Y. (1990). Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Archives of Neurology, 47, 747 - 752
8. Boeve, B.F. (2012). Progressive supranuclear palsy. Parkinsonism and Related Disorders, 18, S192 - 194
9. Boeve, B.F., Lang, A.E. & Litvan, I. (2003). Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Annals of Neurology, 54 (S5), S15 - 19
10. Borroni, B., Alberici, A., Agosti, C., Cosseddu, M., & Padovani, A. (2009). Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy. [Comparative Study]. International Psychogeriatrics/IPA, 21, 463 - 468
11. Borroni, B., Turla, M., Bertasi, V., Agosti, C., Gilberti, N., & Padovani, A (2008). Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes [Comparative Study Multicenter Study]. Archives of gerontology and geriatrics, 47, 53 - 61
12. Boxer, A.L., Geschwind, M.D., Belfor, N., Gorno-Tempini, M.L., Schauer, G.F., Miller, B.L.,.Rosen, H.J. (2006). Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Archives of Neurology, 63, 81 - 86
13. Chan, M. (Producer) (2012) Dementia: A public health priority. Retrieved from http://whqlibdoc.who.int/publications/2012/ 9789241564458-eng.pdf
14. Cole, D.G. & Growdon, J.H. (1994). Therapy for progressive supranuclear palsy: Past and future. Journal of Neural Transmission. Supplementum, 42, 283 - 290
15. Cummings, J.L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D.A. & Gornbein, J. (1994). The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308 - 2314
16. Daniel, S.E., de Bruin, V.M., & Lees, A.J. (1995). The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): A reappraisal. [Comparative Study Research Support, Non-U.S. Gov't Review]. Brain : A Journal of Neurology, 118, 759 - 770
17. Dickson, D.W., Ahmed, Z., Algom, A.A., Tsuboi, Y. & Josephs, K.A. (2010). Neuropathology of variants of progressive supranuclear palsy. Current Opinion in Neurology, 23, 394 - 400
18. Dickson, D.W., Bergeron, C., Chin, S.S., Duyckaerts, C., Horoupian, D., Ikeda, K.,.Litvan, I. (2002). Offi ce of Rare Diseases neuropathologic criteria for corticobasal degeneration. Journal of Neuropathology and Experimental Neurology, 61, 935 - 946
19. Dickson, D.W., Rademakers, R. & Hutton, M.L. (2007). Progressive supranuclear palsy: Pathology and genetics. Brain Pathology, 17, 74 - 82
20. Dubois, B., Pillon, B., Legault, F., Agid, Y. & Lhermitte, F. (1988). Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease. Archives of Neurology, 45, 1194 - 1199
21. Esmonde, T., Giles, E., Gibson, M. & Hodges, J.R. (1996). Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy. Journal of Neurology, 243, 638 - 643
22. Geda, Y.E., Boeve, B.F., Negash, S., Graff-Radford, N.R., Knopman, D.S., Parisi, J.E.,.Petersen, R.C. (2007). Neuropsychiatric features in 36 pathologically confi rmed cases of corticobasal degeneration. Journal of Neuropsychiatry and Clinical Neurosciences, 19, 77 - 80
23. Grober, E., Dickson, D., Sliwinski, M.J., Buschke, H., Katz, M., Crystal, H. & Lipton, R. B. (1999). Memory and mental status correlates of modifi ed Braak staging. Neurobiology of Aging, 20, 573 - 579
24. Gunning, F.M., Cheng, J., Murphy, C.F., Kanellopoulos, D., Acuna, J., Hoptman, M.J.,.Alexopoulos, G.S. (2009). Anterior cingulate cortical volumes and treatment remission of geriatric depression. International Journal of Geriatric Psychiatry, 24, 829 - 836
25. Hadavi, S., Noyce, A.J., Leslie, R.D. & Giovannoni, G. (2011). Stiff person syndrome. Practical Neurology, 11, 272 - 282
26. Hargrave, R. & Rafal, R. (1998). Depression in corticobasal degeneration. Psychosomatics, 39, 481 - 482
27. Hauw, J.J., Daniel, S.E., Dickson, D., Horoupian, D.S., Jellinger, K., Lantos, P.L.,.Litvan, I. (1994). Preliminary NINDS neuropathologic criteria for Steele - Richardson - Olszewski syndrome (progressive supranuclear palsy). Neurology, 44, 2015 - 2019
28. Hoehn-Saric, R., Harris, G.J., Pearlson, G.D., Cox, C.S., Machlin, S.R. & Camargo, E.E. (1991). A fl uoxetine-induced frontal lobe syndrome in an obsessive compulsive patient. Journal of Clinical Psychiatry, 52, 131 - 133
29. Hoehn-Saric, R., Lipsey, J.R. & McLeod, D.R. (1990). Apathy and indifference in patients on fl uvoxamine and fl uoxetine. Journal of Clinical Psychopharmacology, 10, 343 - 345
30. Josephs, K.A. & Dickson, D.W. (2003). Diagnostic accuracy of progressive supranuclear palsy in the society for progressive supranuclear palsy brain bank. Movement Disorders, 18, 1018 - 1026
31. Josephs, K.A., Eggers, S.D., Jack, C.R., Jr & Whitwell, J.L. (2012). Neuroanatomical correlates of the progressive supranuclear palsy corticobasal syndrome hybrid. European Journal of Neurology, 19, 1440 - 1446
32. Josephs, K.A., Jr, Whitwell, J.L., Weigand, S.D., Senjem, M.L., Boeve, B.F., Knopman, D.S.,.Petersen, R.C. (2011). Predicting functional decline in behavioural variant frontotemporal dementia. Brain, 134, 432 - 448
33. Josephs, K.A., Petersen, R.C., Knopman, D.S., Boeve, B.F., Whitwell, J.L., Duffy, J.R.,.Dickson, D.W. (2006). Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology, 66, 41 - 48
34. Josephs, K.A., Tang-Wai, D.F., Edland, S.D., Knopman, D.S., Dickson, D.W., Parisi, J.E.,.Boeve, B.F. (2004). Correlation between antemortem magnetic resonance imaging fi ndings and pathologically confi rmed corticobasal degeneration. Archives of Neurology, 61, 1881 - 1884
35. Josephs, K.A., Whitwell, J.L., Dickson, D.W., Boeve, B.F., Knopman, D.S., Petersen, R.C.,.Jack, C.R., Jr (2008). Voxelbased morphometry in autopsy proven PSP and CBD. Neurobiology of Aging, 29, 280 - 289
36. Josephs, K.A., Whitwell, J.L., Eggers, S.D., Senjem, M.L. & Jack, C.R., Jr (2011). Gray matter correlates of behavioral severity in progressive supranuclear palsy. Movement disorders, 26, 493 - 498
37. Juh, R., Pae, C.U., Kim, T.S., Lee, C.U., Choe, B., & Suh, T. (2005). Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis. [Comparative Study Research Support, Non-U.S. Gov't]. Neuroscience letters, 383, 22 - 27
38. Kemp, W.L., Fitzgerald, J. & White, C.L., III. (2007). Undiagnosed progressive supranuclear palsy in a patient with neuroleptic malignant syndrome due to use of neuroleptics: The utility of autopsy in deaths due to known drug reactions American Journal of Forensic Medicine and Pathology, 28, 59 - 62
39. Kertesz, A. & McMonagle, P. (2010). Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. Journal of the Neurological Sciences, 289, 138 - 143
40. Kertesz, A., McMonagle, P. & Jesso, S. (2011). Extrapyramidal syndromes in frontotemporal degeneration. Journal of Molecular Neuroscience, 45, 336 - 342
41. Klaffke, S., Kuhn, A.A., Plotkin, M., Amthauer, H., Harnack, D., Felix, R. & Kupsch, A. (2006). Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration. Movement Disorders, 21, 1724 - 1727
42. Lang, A.E., Riley, D.E., Bergeron, C. (1994). Cortico-Basal Ganglionic Degeneration. Philadelphia, PA: Saunders
43. Levy, M.L., Cummings, J.L., Fairbanks, L.A., Masterman, D., Miller, B.L., Craig, A.H.,.Litvan, I. (1998). Apathy is not depression. Journal of Neuropsychiatry and Clinical Neurosciences, 10, 314 - 319
44. Ling, H., O'Sullivan, S.S., Holton, J.L., Revesz, T., Massey, L.A., Williams, D.R.,.Lees, A.J. (2010) Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain, 133, 2045 - 2057. doi: 10.1093/brain/awq123
45. Litvan, I., Cummings, J.L. & Mega, M. (1998). Neuropsychiatric features of corticobasal degeneration. Journal of Neurology, Neurosurgery, and Psychiatry, 65, 717 - 721
46. Litvan, I., Grimes, D.A., Lang, A.E., Jankovic, J., McKee, A., Verny, M.,.Pearce, R.K. (1999). Clinical features differentiating patients with postmortem confi rmed progressive supranuclear palsy and corticobasal degeneration. Journal of Neurology, 246 (S2 II), 1 - 5. doi: 9246S001.415 [pii]
47. Litvan, I., Mega, M.S., Cummings, J.L. & Fairbanks, L. (1996). Neuropsychiatric aspects of progressive supranuclear palsy. Neurology, 47, 1184 - 1189
48. Litvan, I., Agid, Y., Goetz, C., Jankovic, J., Wenning, G.K., Brandel, J.P.,.Bartko, J.J. (1997). Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study. [Review]. Neurology, 48, 119 - 125
49. Litvan, I., Cummings, J. L., & Mega, M. (1998). Neuropsychiatric features of corticobasal degeneration. [Comparative Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Journal of Neurology, Neurosurgery, and Psychiatry, 65, 717 - 721
50. Litvan, I., Phipps, M., Pharr, V.L., Hallett, M., Grafman, J. & Salazar, A. (2001). Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy. Neurology, 57, 467 - 473
51. Margari, F., Sicolo, M., Spinelli, L., Mastroianni, F., Pastore, A., Craig, F. & Petruzzelli, M.G. (2012). Aggressive behavior, cognitive impairment, and depressive symptoms in elderly subjects. Neuropsychiatric Disease and Treatment, 8, 347 - 353
52. Massman, P.J., Kreiter, K.T., Jankovic, J., & Doody, R.S. (1996). Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer's disease. Neurology, 46, 720 - 726
53. Mathew, R., Bak, T.H. & Hodges, J.R. (2012). Diagnostic criteria for corticobasal syndrome: A comparative study. Journal of Neurology, Neurosurgery, and Psychiatry, 83, 405 - 410
54. McKhann, G.M., Albert, M.S., Grossman, M., Miller, B., Dickson, D. & Trojanowski, J.Q. (2001). Clinical and pathological diagnosis of frontotemporal dementia: Report of the work group on frontotemporal dementia and Pick's disease. Archives of Neurology, 58, 1803 - 1809
55. Menza, M.A., Cocchiola, J., & Golbe, L.I. (1995). Psychiatric symptoms in progressive supranuclear palsy. Psychosomatics, 36, 550 - 554
56. Meyer, J.H. (2012). Neuroimaging markers of cellular function in major depressive disorder: Implications for therapeutics, personalized medicine, and prevention. Clinical Pharmacology and Therapeutics, 91, 201 - 214
57. Mimura, M., White, R.F. & Albert, M.L. (1997). Corticobasal degeneration: Neuropsychological and clinical correlates. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 94 - 98
58. Neary, D., Snowden, J.S., Gustafson, L., Passant, U., Stuss, D., Black, S.,.Benson, D.F. (1998). Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology, 51, 1546 - 1554
59. Nikolaus, S., Antke, C. & Muller, H.W. (2009). In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia. Behavioural Brain Research, 204, 1 - 31
60. Nomura, T., Inoue, Y., Takigawa, H. & Nakashima, K. (2012). Comparison of REM sleep behaviour disorder variables between patients with progressive supranuclear palsy and those with Parkinson's disease. Parkinsonism and Related Disorders, 18, 394 - 396
61. Nunnemann, S., Kurz, A., Leucht, S. & Diehl-Schmid, J. (2012). Caregivers of patients with frontotemporal lobar degeneration: A review of burden, problems, needs, and interventions. International Psychogeriatrics, 24, 1368 - 1386
62. Oide, T., Ohara, S., Yazawa, M., Inoue, K., Itoh, N., Tokuda, T. & Ikeda, S. (2002). Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia. Acta neuropathologica, 104, 209 - 214
63. Padala, P.R., Padala, K.P., Monga, V., Ramirez, D.A. & Sullivan, D.H. (2012). Reversal of SSRI-associated apathy syndrome by discontinuation of therapy. Annals of pharmacotherapy, 46, e8
64. Palmer, K., Lupo, F., Perri, R., Salamone, G., Fadda, L., Caltagirone, C.,.Cravello, L. (2011). Predicting disease progression in Alzheimer's disease: The role of neuropsychiatric syndromes on functional and cognitive decline. Journal of Alzheimer's Disease, 24, 35 - 45
65. Peters, M.E., Rosenberg, P.B., Steinberg, M., Norton, M.C., Welsh-Bohmer, K.A., Hayden, K.M.,.Lyketsos, C.G. (2012). Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: The Cache County study. American Journal of Geriatric Psychiatry, 20, 416 - 424
66. Pillon, B., Blin, J., Vidailhet, M., Deweer, B., Sirigu, A., Dubois, B., & Agid, Y. (1995). The neuropsychological pattern of corticobasal degeneration: Comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology, 45, 1477 - 1483
67. Rankin, K.P., Mayo, M.C., Seeley, W.W., Lee, S., Rabinovici, G., Gorno-Tempini, M.L.,.Miller, B.L. (2011). Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: Phenotypic comparison to bvFTD with Pick's disease. Journal of Molecular Neuroscience, 45, 594 - 608
68. Rebeiz, J.J., Kolodny, E.H. & Richardson, E.P., Jr (1968). Corticodentatonigral degeneration with neuronal achromasia. Archives of Neurology, 18, 20 - 33
69. Revesz, T., Sangha, H. & Daniel, S.E. (1996). The nucleus raphe interpositus in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Brain, 119, 1137 - 1143
70. Sadowsky, C.H. & Galvin, J.E. (2012). Guidelines for the management of cognitive and behavioral problems in dementia. Journal of the American Board of Family Medicine, 25, 350 - 366
71. Savoiardo, M., Strada, L., Girotti, F., D'Incerti, L., Sberna, M., Soliveri, P. & Balzarini, L. (1989). MR imaging in progressive supranuclear palsy and Shy-Drager syndrome. Journal of Computer Assisted Tomography, 13, 555 - 560
72. Seritan, A.L., Mendez, M.F., Silverman, D.H., Hurley, R.A. & Taber, K.H. (2004). Functional imaging as a window to dementia: Corticobasal degeneration. The Journal of Neuropsychiatry and Clinical Neurosciences, 16, 393 - 399
73. Shibuya, N., Tachibana, H., Okuda, B., & Sugita, M. (2000). [Neuropsychological comparison between corticobasal degeneration and progressive supranuclear palsy]. [Comparative Study]. Nihon Ronen Igakkai zasshi. Japanese Journal of Geriatrics, 37, 541 - 547
74. Sixel-Doring, F., Schweitzer, M., Mollenhauer, B. & Trenkwalder, C. (2009). Polysomnographic fi ndings, videobased sleep analysis and sleep perception in progressive supranuclear palsy. Sleep Medicine, 10, 407 - 415
75. Snowden, J.S., Thompson, J.C., Stopford, C.L., Richardson, A.M., Gerhard, A., Neary, D. & Mann, D.M. (2011). The clinical diagnosis of early-onset dementias: Diagnostic accuracy and clinicopathological relationships. Brain, 134, 2478 - 2492
76. Sorbi, S., Hort, J., Erkinjuntti, T., Fladby, T., Gainotti, G., Gurvit, H.,.Scheltens, P. (2012). EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia. European Journal of Neurology, 19, 1159 - 1179
77. Steele, J.C., Richardson, J.C. & Olszewski, J. (1964). Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Archives of Neurology, 10, 333 - 359
78. Sudmeyer, M., Pieperhoff, P., Ferrea, S., Krause, H., Groiss, S.J., Elben, S.,.Schnitzler, A. (2012). Longitudinal deformationbased morphometry reveals spatio-temporal dynamics of brain volume changes in patients with corticobasal syndrome. PloS ONE, 7, e41873. doi: 10.1371/journal.pone. 0041873
79. Teune, L.K., Bartels, A.L., de Jong, B.M., Willemsen, A.T., Eshuis, S.A., de Vries, J.J.,.Leenders, K.L. (2010). Typical cerebral metabolic patterns in neurodegenerative brain diseases. Movement disorders: Offi cial Journal of the Movement Disorder Society, 25, 2395 - 2404
80. Vanvoorst, W A., Greenaway, M. C., Boeve, B. F., Ivnik, R. J., Parisi, J. E., Eric Ahlskog, J.,... Josephs, K. A. (2008). Neuropsychological fi ndings in clinically atypical autopsy confi rmed corticobasal degeneration and progressive supranuclear palsy
81. [Letter Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Parkinsonism & related disorders, 14, 376 - 378
82. Wenning, G.K., Litvan, I., Jankovic, J., Granata, R., Mangone, C.A., McKee, A., Pearce, R.K. (1998). Natural history and survival of 14 patients with corticobasal degeneration confi rmed at postmortem examination. Journal of Neurology, Neurosurgery, and Psychiatry, 64, 184 - 189
83. Whitwell, J.L., Jack, C.R., Jr, Boeve, B.F., Parisi, J.E., Ahlskog, J.E., Drubach, D.A.,.Josephs, K.A. (2010). Imaging correlates of pathology in corticobasal syndrome. Neurology, 75, 1879 - 1887
84. symptoms in neurodegenerative disease: Rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. Journal of Clinical Psychiatry, 72, 126 - 133
85. Yatabe, Y., Hashimoto, M., Kaneda, K., Honda, K., Ogawa, Y., Yuuki, S.,.Ikeda, M. (2011). Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic. [Comparative Study Research Support, Non-U.S. Govt]. Psychogeriatrics: The offi cial Journal of the Japanese Psychogeriatric Society, 11, 54 - 59
86. Zahodne, L.B., Bernal-Pacheco, O., Bowers, D., Ward, H., Oyama, G., Limotai, N.,.Okun, M.S (2012). Are selective serotonin reuptake inhibitors associated with greater apathy in Parkinson's disease? Journal of Neuropsychiatry and Clinical Neurosciences, 24, 326 - 330
87. Whitwell, J.L., Jack, C.R., Jr, Parisi, J.E., Knopman, D.S., Boeve, B.F., Petersen, R.C.,.Josephs, K.A. (2007). Rates of cerebral atrophy differ in different degenerative pathologies. Brain, 130, 1148 - 1158
88. Williams, D.R. & Lees, A.J. (2009). Progressive supranuclear palsy: Clinicopathological concepts and diagnostic challenges. Lancet Neurology, 8, 270 - 279
89. Wimo, A. & Prince, M. (Producer) (2010). The global economic impact of dementia. World Alzheimer Report 2010. Retrieved from: Http://www.alz.org/ documents/national/world-alzheimer-Report-2010-summary(1).pdf
90. Woolley, J.D., Khan, B.K., Murthy, N.K., Miller, B.L. & Rankin, K.P. (2011). The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: Rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. Journal of Clinical Psychiatry, 72, 126 - 133
91. Yatabe, Y., Hashimoto, M., Kaneda, K., Honda, K., Ogawa, Y., Yuuki, S.,.Ikeda, M. (2011). Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic. [Comparative Study Research Support, Non-U.S. Govt]. Psychogeriatrics: The offi cial Journal of the Japanese Psychogeriatric Society, 11, 54 - 59
92. Zahodne, L.B., Bernal-Pacheco, O., Bowers, D., Ward, H., Oyama, G., Limotai, N.,.Okun, M.S (2012). Are selective serotonin reuptake inhibitors associated with greater apathy in Parkinson's disease? Journal of Neuropsychiatry and Clinical Neurosciences, 24, 326 - 330